Cargando…
New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia
A number of new cholesterol-lowering drugs have been recently developed and approved, enriching the pharmacological armamentarium beyond and above statins. Ezetimibe, available since two decades, and bempedoic acid, a new drug inhibiting the same biosynthetic pathway targeted by statins but at an ea...
Autores principales: | Pirillo, Angela, Catapano, Alberico L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915986/ https://www.ncbi.nlm.nih.gov/pubmed/34980867 http://dx.doi.org/10.1097/MED.0000000000000706 |
Ejemplares similares
-
Applying implementation science to improve care for familial hypercholesterolemia
por: Jones, Laney K., et al.
Publicado: (2022) -
HDL functionality in type 1 and type 2 diabetes: new insights
por: Chapman, M. John
Publicado: (2022) -
The role of endocrine-disrupting phthalates and bisphenols in cardiometabolic disease: the evidence is mounting
por: Lucas, Andrew, et al.
Publicado: (2022) -
New algorithms for treating homozygous familial hypercholesterolemia
por: Tromp, Tycho R., et al.
Publicado: (2022) -
Angiopoietin-like 3 inhibition and the liver: less is more?
por: Oostveen, Reindert F., et al.
Publicado: (2023)